The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-phenethylimidazo[1,2-a]quinoxalin-4-amine ID: ALA2420577
PubChem CID: 3656000
Max Phase: Preclinical
Molecular Formula: C18H16N4
Molecular Weight: 288.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc(CCNc2nc3ccccc3n3ccnc23)cc1
Standard InChI: InChI=1S/C18H16N4/c1-2-6-14(7-3-1)10-11-19-17-18-20-12-13-22(18)16-9-5-4-8-15(16)21-17/h1-9,12-13H,10-11H2,(H,19,21)
Standard InChI Key: ZOZFYKGGFJBPBL-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
7.9053 -6.1712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1910 -6.5840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1915 -7.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9060 -7.8213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6207 -7.4083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3348 -7.8202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0493 -7.4073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0490 -6.5823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3342 -6.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6196 -6.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5775 -6.0324 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9127 -5.2785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7331 -5.3642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4770 -7.8218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4770 -8.6470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7627 -9.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7627 -9.8845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4581 -10.2867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4706 -11.1118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7625 -11.5351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0418 -11.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0293 -10.3087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
1 10 1 0
5 10 2 0
11 12 1 0
12 13 2 0
1 13 1 0
2 11 2 0
3 14 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
14 15 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 288.35Molecular Weight (Monoisotopic): 288.1375AlogP: 3.54#Rotatable Bonds: 4Polar Surface Area: 42.22Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.94CX LogP: 3.03CX LogD: 3.03Aromatic Rings: 4Heavy Atoms: 22QED Weighted: 0.62Np Likeness Score: -1.36
References 1. Li B, Cociorva OM, Nomanbhoy T, Weissig H, Li Q, Nakamura K, Liyanage M, Zhang MC, Shih AY, Aban A, Hu Y, Cajica J, Pham L, Kozarich JW, Shreder KR.. (2013) Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors., 23 (18): [PMID:23916259 ] [10.1016/j.bmcl.2013.06.087 ]